Corbus Pharmaceuticals (CRBP) announced the dosing of the first subject in the single ascending dose / multiple ascending dose portion of the Phase 1 trial of CRB-913 for the treatment of obesity ...
Shares of Corbus Pharmaceuticals Holdings Inc. CRBP slipped 4.66% to $5.52 Friday, on what proved to be an all-around dismal trading session for the stock market, with the NASDAQ Composite Index ...
Shares of Corbus Pharmaceuticals Holdings Inc. CRBP slid 2.95% to $5.92 Wednesday, on what proved to be an all-around dismal trading session for the stock market, with the NASDAQ Composite Index ...
Icon Lynne McGranger has closed a chapter on her illustrious soap opera career. The actress filmed her final scenes for Home and Away, with the series sharing moving scenes from her last day ...
Lynne McGranger has completed her final day on the set of Home and Away. And the iconic actress was surrounded by her loving costars as she sat down for an outdoor farewell dinner on Wednesday ...
Corbus Pharmaceuticals Holdings Inc. (NASDAQ:CRBP) stock has hit a 52-week low, trading at $5.91, down dramatically from its... Corbus Pharmaceuticals Holdings Inc. (NASDAQ:CRBP) stock has hit a ...
March 28, 2025 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) (“Corbus” or the “Company”), an oncology and obesity company with a diversified portfolio, announced today the ...
Thank you for reporting this station. We will review the data in question. You are about to report this weather station for bad data. Please select the information that is incorrect.
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results